ATIM-32. PERSONALIZED NEOANTIGEN-TARGETING VACCINE GENERATES ROBUST SYSTEMIC AND INTRATUMORAL T CELL RESPONSES IN GLIOBLASTOMA (GBM) PATIENTS
David A. Reardon(Dana-Farber Cancer Institute), Patrick A. Ott(Dana-Farber Cancer Institute), Aviv Regev(Broad Institute), Itay Tirosh(Weizmann Institute of Science), Evisa Gjini(Brigham and Women's Hospital), Keith L. Ligon(Brigham and Women's Hospital), Mario L. Suvà(Broad Institute), Edward F. Fritsch(Broad Institute), Patrick Y. Wen(Dana-Farber Cancer Institute), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Annabelle Anandappa(Harvard University), Nathan D. Mathewson(Broad Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Nir Hacohen(Cambridge Hospital), Kenneth J. Livak(Broad Institute), Scott J. Rodig(Brigham and Women's Hospital), E. Antonio Chiocca(Harvard University), Anita Giobbie‐Hurder(Institute for Tourism), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Jing Sun(Broad Institute), Shuqiang Li(Dana-Farber Cancer Institute), Derin B. Keskin(Dana-Farber Cancer Institute), Christine McCluskey(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan))
Cited by 0
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis
|Nature Protocols|2013|9.1k
Spatial reconstruction of single-cell gene expression data
|Nature Biotechnology|2015|7.6k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k